No effect of Trp64Arg β3-adrenoceptor polymorphism on the plasma leptin concentration in Pima Indians

Metabolism: Clinical and Experimental

Volumn 47, Issue 12, 1998, Pages 1525-1527

  Snitker, Søren ^a   Nicolson, Margery ^b   Shuldiner, Alan R ^b   Silver, Kristi ^b   Ravussin, Eric ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; INSULIN;

ADULT; AMERICAN INDIAN; ARTICLE; BETA ADRENERGIC STIMULATION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; THERMOGENESIS; ALLELE; BLOOD; BODY COMPOSITION; BODY MASS; BODY WEIGHT; GENETICS; GENOTYPE; REGRESSION ANALYSIS;

ADULT; ALLELES; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; FEMALE; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN; MALE; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; REGRESSION ANALYSIS;

EID: 0032254375     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90081-6     Document Type: Article

References (18)

1. Zhang Y, Proenca R, Maffei M, et al: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
2. Collins S, Kuhn C, Petro AE, et al: Role of leptin in fat regulation. Nature 380:677, 1996
3. Haynes GW, Morgan DA, Walsh SA, et al: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270-278, 1997
4. Collins S, Surwitt RS: Pharmacologic manipulation of ob expression in a dietary model of obesity. J Biol Chem 271:9437-9440, 1996
5. Gettys TW, Harkness PJ, Watson PM: The β3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 137:4054-4057, 1996
6. Snitker S, Pratley RE, Nicolson M, et al: Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res 5:338-340, 1997
7. Walston J, Silver K, Bogardus C, et al: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 333:343-347, 1995
8. Widén E, Letho M, Kanninen T, et al: Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
9. Clément K, Vaisse C, Manning BS, et al: Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
10. Candelore MR, Deng L, Tota LM, et al: Pharmacological characterization of a recently described human β3-adrenergic receptor mutant. Endocrinology 137:2638-2641, 1996
11. Piétri-Rouxel F, St John Manning B, Gros J, et al: The biochemical effect of the naturally occurring Trp64 → Arg mutation on human β3-adrenoceptor activity. Eur J Biochem 247:1174-1179, 1997
12. Giacobino J-P: Role of the β3-adrenoceptor in the control of leptin expression. Horm Metab Res 28:633-637, 1996
13. Deng C, Paolino-Giacobino A, Kuehne F, et al: Respective degree of expression of β1-, β2- and β3-adrenoceptors in human brown and white adipose tissues. Br J Pharmacol 118:929-934, 1994
14. Krief S, Lönnqvist F, Raimbault S, et al: Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
15. Emilsson V, Liu YL, Cawthorne MA, et al: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46:313-316, 1997
16. 3-adrenoceptor in the regulation of body composition. J Clin Invest 100:1098-1106, 1997
17. Susulic VS, Frederich RC, Lawitts J, et al: Targeted disruption of the β3-adrenoceptor gene. J Biol Chem 270:29483-29492, 1995
18. Licinio J, Mantzoros C, Negrão AB, et al: Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 3:575-579, 1997